Effects of alprazolam and fluoxetine on morphine sensitization in mice

Physiological Research

Volumn 51, Issue 4, 2002, Pages 417-423

  Votava, M ^a   Krsiak M ^a   Moravec, V ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Alprazolam; Fluoxetine; Locomotion; Morphine; Sensitization

Indexed keywords

ALPRAZOLAM; BENZODIAZEPINE DERIVATIVE; FLUOXETINE; MORPHINE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG DEPENDENCE; DRUG EFFECT; DRUG SENSITIZATION; LOCOMOTION; MALE; MOUSE; NONHUMAN; PATHOGENESIS; TIME SERIES ANALYSIS;

ALPRAZOLAM; ANIMALS; FLUOXETINE; MALE; MICE; MICE, INBRED ICR; MORPHINE; MOTOR ACTIVITY; NARCOTIC ANTAGONISTS; NARCOTICS;

EID: 0036404950     PISSN: 08628408     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Babbini M, Davis WM: Time-dose relationships for locomotor activity effects of morphine after acute or repeated treatment. Br J Pharmacol 46: 213-224, 1972.
2. Covington HE, Miczek KA: Increased sensitivity to the reinforcing effects of cocaine following behavioral sensitization to morphine. Soc Neurosci Abstr 25: 1575, 1999.
3. Cunningham CL, Noble D: Conditioned activation induced by ethanol: Role in sensitization and conditioned place preference. Pharmacol Biochem Behav 43: 307-313, 1992.
4. Darke SG, Ross JE, Hall WD: Benzodiazepine use among injecting heroin users. Med JAust 162: 645-647, 1995.
5. Di Chiara G, Acquas E, Carboni E: Role of the mesolimbic dopamine in the motivational effects of drugs: Brain dialysis and place preference studies. In: The Mesolimbic Dopamine System: From Motivation to Action, P Willner, J Scheel-kruger (eds), John Wiley, New York, 1991, pp 367-384.
6. Finlay JM, Damsma G, Fibiger HC: Benzodiazepine-induced decreases in extracellular concentrations of dopamine in the nucleus accumbens after acute and repeated administration. Psychopharmacology (Berl) 106: 202-208, 1992.
7. Fuxe K, Agnati L, Bolme P: The possible involvement of GABA mechanisms in the action of benzodiazepines on central catecholamine neurons. Psychopharmacol Bull 11: 55-56, 1975.
8. Gossop M, Marsden J, Stewart D, Lehmann P, Edwards C, Wilson A, Segar G: Substance use, health and social problems of service users at 54 drug treatment agencies. Intake data from the National Treatment Outcome Research Study. Br J Psychiatry 173: 166-171, 1998.
9. Gray AM: Effect of alprazolam on opiate withdrawal: A combined behavioural and microdialysis study. Eur J Pharmaco1l 313: 73-77, 1996.
10. Hascoet M, Bourin M: Anticonflict effect of alpidem as compared with the benzodiazepine alprazolam in rats. Pharmacol Biochem Behav 56: 317-324, 1997.
11. Johnson SW, North RA: Opioids excite dopamine neurons by hyperpolarization of local interneurons. J Neurosci 12: 483-488, 1992.
12. Joyce EM, Iversen SD: The effect of morphine applied locally to mesencephalic dopamine cell bodies on spontaneous motor activity in the rat. Neurosci Lett 14: 207-212, 1979.
13. Kršiak M, Šulcová A: Differential effects of six structurally related benzodiazepines on some ethological measures of timidity, aggression and locomotion in mice. Psychopharmacology (Berl) 101: 396-402, 1990.
14. 3H]acetylcholine to nicotinic receptors. Neuropharmacology 24: 527-531, 1985.
15. Kumar R, Mitchell E, Stolerman IP: Disturbed patterns of behaviour in morphine tolerant and abstinent rats. Br J Pharmacol 42: 473-484, 1971.
16. Kuribara H: Effects of interdose interval on ambulatory sensitization to methamphetamine, cocaine and morphine in mice. Eur J Pharmacol 316: 1-5, 1996.
17. Leri F, Franklin KB: Effects of diazepam on conditioned place preference induced by morphine or amphetamine in the rat. Psychopharmacology (Berl) 150: 351-360, 2000.
18. Masur J, Oliveira De Souza ML, Zwicker AP: The excitatory effect of ethanol: Absence in rats, no tolerance and increased sensitivity in mice. Pharmacol Biochem Behav 24: 1225-1228, 1986.
19. Petry NM, Bickel WK: Polydrug abuse in heroin addicts: A behavioral economic analysis. Addiction 93: 321-335, 1998.
20. Post RM, Rose H: Increasing effects of repetitive cocaine administration in the rat. Nature 260: 731-732, 1976.
21. Robinson TE, Becker JB: Enduring changes in brain and behavior produced by chronic amphetamine administration: A review and evaluation of animal models of amphetamine psychosis. Brain Res 396: 157-198, 1986.
22. 1 receptor regulated signal transduction in rat striatal neurons and its facilitation by glucocorticoid receptor activation: Possible role in behavioral sensitization. Neurochem Res 21: 1417-1423, 1996.
23. Segal DS, Mandell AJ: Long-term administration of d-amphetamine: Progressive augmentation of motor activity and stereotypy. Pharmacol Biochem Behav 2: 249-255, 1974.
24. Shoaib M, Stolerman IP, Kumar RC: Nicotine-induced place preferences following prior nicotine exposure in rats. Psychopharmacology (Berl) 113: 445-452, 1994.
25. Sills TL, Fletcher PJ: Fluoxetine attenuates morphine-induced locomotion and blocks morphine-sensitization. Eur J Pharmacol 337: 161-164, 1997.
26. Spanagel R, Almeida OF, Shippenberg TS: Long lasting changes in morphine-induced mesolimbic dopamine release after chronic morphine exposure. Synapse 14: 243-245, 1993.
27. Stephens DN, Elliman TD, Dunworth SJ: State-dependent behavioural sensitization: Evidence from a chlordiazepoxide state. Behav Pharmacol 11: 161-167, 2000.
28. Suzuki T, Tsuda M, Narita M, Funada M, Mizoguchi H, Misawa M: Diazepam pretreatment suppresses morphine withdrawal signs in the mouse. Life Sci 58: 349-357, 1996.
29. Valverde O, Maldonado R, Mico JA, Gibert-Rahola J: Study of the mechanisms involved in behavioral changes induced by flunitrazepam in morphine withdrawal. Prog Neuropsychopharmacol Biol Psychiatry 19: 973-991, 1995.
30. Vezina P, Kalivas PW, Stewart J: Sensitization occurs to the locomotor effects of morphine and the specific mu opioid receptor agonist, DAGO, administered repeatedly to the ventral tegmental area but not to the nucleus accumbens. Brain Res 417: 51-58, 1987.
31. Wise RA: Opiate reward: Sites and substrates. Neurosci Biobehav Rev 13: 129-133, 1989.
32. Woods JH, Winger G: Current benzodiazepine issues. Psychopharmacology (Berl) 118: 107-115, 1995.